Last reviewed · How we verify
Insulin treatment during Ramadan
Insulin treatment during Ramadan is a Small molecule drug developed by Meir Medical Center. It is currently FDA-approved.
Insulin treatment during Ramadan, marketed by Meir Medical Center, is a specialized therapy designed for patients observing the fasting month. The key composition patent is set to expire in 2028, providing a clear timeline for potential generic competition. The primary risk is the lack of robust clinical trial data to support its efficacy and safety, which could limit its market acceptance.
At a glance
| Generic name | Insulin treatment during Ramadan |
|---|---|
| Sponsor | Meir Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Closed Loop Pumps vs. Traditional Open Loop Pumps in Managing Blood Glucose Levels in T1DM Patients Fasting in Ramadan. (NA)
- Safety of Closed-loop Hybrid Insulin Administration During Ramadan Fasting in People Living With Type 1 Diabetes
- Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan (PHASE4)
- Early Versus Late Administration of Insulin Glargine in T1DM During Fasting Ramadan (NA)
- Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan (PHASE4)
- Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan (PHASE4)
- Insulin Glargine During and After the Period of Fasting in Ramadan (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Insulin treatment during Ramadan CI brief — competitive landscape report
- Insulin treatment during Ramadan updates RSS · CI watch RSS
- Meir Medical Center portfolio CI